Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Neural Transm (Vienna). 2019 Jul 22;126(10):1303–1312. doi: 10.1007/s00702-019-02043-7

Table 1.

Descriptive summary of the patients’ data

All subjects (n=58) Patients with normal
cognition at baseline with
2-yr follow-up data (n=34)
Gender F 24 (41.4%) 13 (38.2%)
M 34 (58.6%) 21 (61.8%)
Education Basic 10 (17.2%) 3 (8.8%)
High school 34 (58.6%) 21 (61.8%)
University 14 (24.1%) 10 (29.4%)
Motor phenotype Intermediate 11 (19.0%) 7 (20.6%)
PIGD 34 (58.6%) 20 (58.8%)
TD 13 (22.4%) 7 (20.6%)
Age at baseline (years) 64.0 ± 8.1,
65.0 (45.0–82.0)		 63.1 ± 7.9,
64.0 (50.0–82.0)
Age at onset of PD (years) 58.4 ± 8.4,
60.0 (40.0–76.0)		 57.7 ± 8.1,
59.0 (40.0–76.0)
Duration of PD at baseline (years) 5.6 ± 4.1,
4.0 (1.0–20.0)		 5.3 ± 3.4,
4.5 (1.0–15.0)
Daily L-dopa equivalent 503.8 ± 365.2,
412.5 (27.0–2010.0)		 402.1 ± 291.9,
362.0 (54.0–1115.0)

Legend: FUP (follow-up), PD (Parkinson’s disease), PIGD (postural instability and gait disorder), TD (tremor-dominant)